Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases

AR Ahmed, MV Dahl - Archives of dermatology, 2003 - jamanetwork.com
Objectives The purpose of the meeting of the Consensus Development Group was to
critically evaluate the current published data on the use of intravenous immunoglobulin
(IVIg) therapy in the treatment of autoimmune mucocutaneous blistering diseases (AMBDs)
and to discuss the industrial preparation and safety features of this biologic agent.
Participants The participants were physicians who frequently treat patients with these
diseases and included dermatologists, oral medicine specialists, ophthalmologists, and …